• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 102208-905
Device Problem Imprecision (1307)
Patient Problem Hypoglycemia (1912)
Event Date 07/12/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.The investigation was performed on the user synced glucose data on data management system (dms), which is an eversense cloud platform.Based on the investigation analysis, the reported mismatch was confirmed and the low glucose alert was not asserted at the time of incident because the sg value did not cross below the low glucose alert setting of 70 mg/dl.A review of the system performance via a dms analysis did not reveal any abnormalities and the system was working within expectations.Overall, the blood glucose (bg) values entered as calibrations fit sensor glucose (sg) trends well, with some occasional differences due to lag and calibrations that were entered during the period of rapid glucose changes.There were many gaps in the glucose data due to transmitter disconnections and calibrations were entered after the gap.This is not the recommended usage of the system.The customer was recommended to use the system consistently so that the system would adjust its glucose according to entered calibrations.The customer was also recommended to calibrate when the glucose is stable to minimize inaccuracies.The customer is currently using the system with up to date glucose information and has not reported any additional concerns.No further investigation was found necessary for this complaint.
 
Event Description
Senseonics was made aware of a customer experiencing a hypoglycemia event on (b)(6) 2023 at 9:38 pm.The customer reported that the measured blood glucose (bg) value was 58 mg/dl where as the sensor glucose (sg) reading was 99 mg/dl.The customer did not receive a low glucose alert because the sg value did not cross below the low alert threshold which was set at 70 mg/dl.The customer self resolved the incident by eating some sugar.Th customer did not require any medical attention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18117342
MDR Text Key327888396
Report Number3009862700-2023-00279
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/12/2023
Device Model Number102208-905
Device Catalogue NumberFG-3500-05-001
Device Lot Number134240
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/25/2023
Initial Date FDA Received11/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/12/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-